BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 16, 2025
See today's BioWorld
Home
» June biopharma deals hit year records, while M&As wane
To read the full story,
subscribe
or
sign in
.
June biopharma deals hit year records, while M&As wane
July 24, 2020
By
Karen Carey
No Comments
The top two biggest money biopharma deals in 2020 occurred in June, putting the month ahead of all other months for the year in terms of deal values and volumes.
BioWorld
Analysis and data insight
Deals and M&A
